South Africa
South Africa has concluded the sale of the AstraZeneca COVID-19 vaccines to other African Union member states, the health ministry said Sunday.
The country had acquired the jabs but did not use, becuase it failed to offer minimal protection against mild to moderate illness caused by the local variant.
Last month, Johannesburg had suspended AstraZeneca inoculations after a small trial.
At the time, South Africa had received 1 million AstraZeneca doses from India. The delivery of another 500,000 doses was pending.
The ministry said it had in the past weeks worked to ensure that all member states identified by the AU had obtained all regulatory approvals, permits and licences to roll out the vaccines.
The first batch of vaccines being delivered will benefit 9 member states.
The balance will be collected this week to be delivered to 5 other member states.
The statement did not mention prices nor the countries that had purchased the vaccines.
Go to video
UNICEF secures agreement to cut malaria vaccine costs
00:54
A third of Japan-donated Mpox vaccines wasted in DRC due to storage challenges
01:31
South Africa starts clinical trials on first locally developed oral cholera vaccine
01:07
WHO reports rapid spread of Mpox with 17 deaths in Africa over recent weeks
01:01
US limits new Covid-19 vaccines to high-risk groups, removes Pfizer for under-5s
01:29
US medication safety agency approves biannual preventive HIV shot